Browse Conditions Browse Medicines

NICE publish updated quality standard for hypertension in pregnancy

For Hypertension in pregnancy and Hypertension

The National Institute for Health and Care Excellence (NICE) have published their updated quality standard on hypertension in pregnancy.

This quality standard covers diagnosing and managing hypertension (high blood pressure) and pre-eclampsia during pregnancy, labour and birth. It also covers advice for women with hypertension who may become pregnant and postnatal care for women who have had hypertension or pre-eclampsia. It describes high-quality care in priority areas for improvement.

About hypertension in pregnancy
Most women don’t have problems with their blood pressure during pregnancy. A few women do have high blood pressure (hypertension), either because they had it before they were pregnant or they develop it during pregnancy. The right way to manage high blood pressure varies, but if it’s not well controlled it can lead to complications for both the mother and her baby. It can also increase the risk of pre-eclampsia, a sudden rise in blood pressure after 20 weeks of pregnancy that can be dangerous if it’s not treated quickly, so extra care and check-ups are very important.

The NICE guideline to make a difference by making sure:
  • pregnant women who develop high blood pressure are offered the right tests and treatments to keep their blood pressure within a safe range for them and their baby
  • women who are taking medicine for blood pressure and want to try for a baby (or have found they are pregnant) are given the best advice about the safety of different medicines for their baby
  • women have good advice and support, including how to spot signs of pre-eclampsia (see the NHS website) and what to do
  • care teams give women the right follow-up care and check-ups after they have given birth

NHS website for hypertension
Contains public sector information licensed under the Open Government Licence v3.0.
Accessed 24/07/19
Links available in full article.

© NICE [2019]

Hypertension in pregnancy: diagnosis and management. NICE guideline [NG133]. Published date: June 2019
Available from: See Link below. All rights reserved. Subject to Notice of rights
NICE guidance is prepared for the National Health Service in England. All NICE guidance is subject to regular review and may be updated or withdrawn. NICE accepts no responsibility for the use of its content in this product/publication.

The information provided by NICE was accurate at the time this article was issued.

NICE quality standard for hypertension in pregnancy

Reporting of suspected adverse reactions

Reporting suspected adverse reactions (side effects) after authorisation of the medicinal product is important. It allows continued monitoring of the benefit/risk balance of the medicinal product. Healthcare professionals or patients are asked to report any suspected adverse reactions via the Yellow Card Scheme at or search for MHRA Yellow Card in the Google Play or Apple App Store.

Disclaimer: This site is designed to offer information for general educational purposes only. The health information furnished on this site and the interactive responses are not intended to be professional advice and are not intended to replace personal consultation with a qualified physician, pharmacist, or other healthcare professional. We cannot provide individual medical advice. You must always seek the advice of a professional for questions related to a disease, disease symptoms, and appropriate therapeutic treatments.

About Hypertension in pregnancy About Hypertension